Cardlytics Inc (CDLX)

$11.94

-0.24

(-1.97%)▲

Market is closed - opens 7 PM, 19 Apr 2024

Insights on Cardlytics Inc

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 67.92M → 89.16M (in $), with an average increase of 8.6% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, 33.03M → -100.83M (in $), with an average decrease of 164.6% per quarter

  • Vs CMPR

    In the last 1 year, Cimpress N.v. has given 105.3% return, outperforming this stock by 31.5%

  • Vs IPG

    In the last 3 years, Cardlytics Inc has experienced a drawdown of -90.2%, however Interpublic Group Of Companies, Inc. resisted the overall trend and outperformed by 78.8%

Performance

  • $11.84
    $12.34
    $11.94
    downward going graph

    0.84%

    Downside

    Day's Volatility :4.01%

    Upside

    3.2%

    downward going graph
  • $4.94
    $19.57
    $11.94
    downward going graph

    58.63%

    Downside

    52 Weeks Volatility :74.76%

    Upside

    38.99%

    downward going graph

Returns

PeriodCardlytics IncSector (Communication Services)Index (Russel 2000)
3 Months
98.37%
8.3%
0.0%
6 Months
4.28%
19.0%
0.0%
1 Year
73.75%
36.5%
-1.5%
3 Years
-89.96%
4.1%
-21.8%

Highlights

Market Capitalization
634.0M
Book Value
$3.39
Earnings Per Share (EPS)
-3.48
Wall Street Target Price
17.67
Profit Margin
-43.56%
Operating Margin TTM
-8.67%
Return On Assets TTM
-6.29%
Return On Equity TTM
-77.77%
Revenue TTM
309.2M
Revenue Per Share TTM
8.47
Quarterly Revenue Growth YOY
8.1%
Gross Profit TTM
115.4M
EBITDA
-37.2M
Diluted Eps TTM
-3.48
Quarterly Earnings Growth YOY
-0.57
EPS Estimate Current Year
0.01
EPS Estimate Next Year
0.4
EPS Estimate Current Quarter
0.12
EPS Estimate Next Quarter
-0.21

Analyst Recommendation

Buy
    75%Buy
    25%Hold
    0
    0%Sell
Based on 8 Wall street analysts offering stock ratings for Cardlytics Inc(by analysts ranked 0 to 5 stars)
Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
2
2
3
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 47.99%

Current $11.94
Target $17.67

Company Financials

FY18Y/Y Change
Revenue
150.7M
↑ 15.59%
Net Income
-53.0M
↑ 170.06%
Net Profit Margin
-35.2%
↓ 20.13%
FY19Y/Y Change
Revenue
210.4M
↑ 39.65%
Net Income
-17.7M
↓ 66.65%
Net Profit Margin
-8.41%
↑ 26.79%
FY20Y/Y Change
Revenue
186.9M
↓ 11.19%
Net Income
-58.5M
↑ 230.49%
Net Profit Margin
-31.29%
↓ 22.88%
FY21Y/Y Change
Revenue
267.1M
↑ 42.93%
Net Income
-128.6M
↑ 119.88%
Net Profit Margin
-48.13%
↓ 16.84%
FY22Y/Y Change
Revenue
298.5M
↑ 11.76%
Net Income
-465.3M
↑ 261.89%
Net Profit Margin
-155.85%
↓ 107.72%
FY23Y/Y Change
Revenue
309.2M
↑ 3.57%
Net Income
-134.7M
↓ 71.05%
Net Profit Margin
-43.56%
↑ 112.29%
Q3 FY22Q/Q Change
Revenue
72.7M
↓ 3.58%
Net Income
49.6M
↓ 139.26%
Net Profit Margin
68.2%
↑ 235.68%
Q4 FY22Q/Q Change
Revenue
82.5M
↑ 13.47%
Net Income
-371.9M
↓ 849.92%
Net Profit Margin
-450.72%
↓ 518.92%
Q1 FY23Q/Q Change
Revenue
67.9M
↓ 17.67%
Net Income
33.0M
↓ 108.88%
Net Profit Margin
48.64%
↑ 499.36%
Q2 FY23Q/Q Change
Revenue
76.7M
↑ 12.92%
Net Income
-23.5M
↓ 171.15%
Net Profit Margin
-30.65%
↓ 79.29%
Q3 FY23Q/Q Change
Revenue
79.0M
↑ 3.0%
Net Income
-24.0M
↑ 1.95%
Net Profit Margin
-30.33%
↑ 0.32%
Q4 FY23Q/Q Change
Revenue
89.2M
↑ 12.86%
Net Income
-100.8M
↑ 320.75%
Net Profit Margin
-113.09%
↓ 82.76%
FY18Y/Y Change
Total Assets
153.8M
↑ 52.61%
Total Liabilities
101.8M
↓ 67.11%
FY19Y/Y Change
Total Assets
224.3M
↑ 45.88%
Total Liabilities
81.0M
↓ 20.38%
FY20Y/Y Change
Total Assets
422.5M
↑ 88.37%
Total Liabilities
265.3M
↑ 227.4%
FY21Y/Y Change
Total Assets
1.3B
↑ 199.1%
Total Liabilities
573.1M
↑ 115.98%
FY22Y/Y Change
Total Assets
691.2M
↓ 45.3%
Total Liabilities
479.6M
↓ 16.31%
FY23Y/Y Change
Total Assets
574.1M
↓ 16.94%
Total Liabilities
439.3M
↓ 8.4%
Q3 FY22Q/Q Change
Total Assets
1.1B
↓ 2.13%
Total Liabilities
485.8M
↓ 7.53%
Q4 FY22Q/Q Change
Total Assets
691.2M
↓ 35.18%
Total Liabilities
479.6M
↓ 1.27%
Q1 FY23Q/Q Change
Total Assets
684.6M
↓ 0.96%
Total Liabilities
452.3M
↓ 5.7%
Q2 FY23Q/Q Change
Total Assets
633.3M
↓ 7.49%
Total Liabilities
397.2M
↓ 12.17%
Q3 FY23Q/Q Change
Total Assets
634.9M
↑ 0.25%
Total Liabilities
409.6M
↑ 3.11%
Q4 FY23Q/Q Change
Total Assets
574.1M
↓ 9.57%
Total Liabilities
439.3M
↑ 7.27%
FY18Y/Y Change
Operating Cash Flow
-19.0M
↓ 14.06%
Investing Cash Flow
-7.3M
↑ 345.78%
Financing Cash Flow
65.2M
↑ 199.58%
FY19Y/Y Change
Operating Cash Flow
11.5M
↓ 160.32%
Investing Cash Flow
-11.0M
↑ 50.1%
Financing Cash Flow
44.2M
↓ 32.23%
FY20Y/Y Change
Operating Cash Flow
-7.6M
↓ 166.32%
Investing Cash Flow
-10.1M
↓ 8.19%
Financing Cash Flow
206.4M
↑ 367.26%
FY21Y/Y Change
Operating Cash Flow
-38.5M
↑ 407.02%
Investing Cash Flow
-506.7M
↑ 4908.35%
Financing Cash Flow
486.0M
↑ 135.43%
FY22Y/Y Change
Operating Cash Flow
-53.9M
↑ 39.93%
Investing Cash Flow
-15.8M
↓ 96.89%
Financing Cash Flow
-40.0M
↓ 108.23%
Q3 FY22Q/Q Change
Operating Cash Flow
-14.4M
↑ 116.14%
Investing Cash Flow
-3.3M
↓ 22.6%
Financing Cash Flow
-6.0K
↓ 99.98%
Q4 FY22Q/Q Change
Operating Cash Flow
-13.1M
↓ 9.24%
Investing Cash Flow
-3.2M
↓ 4.57%
Financing Cash Flow
-179.0K
↑ 2883.33%
Q1 FY23Q/Q Change
Operating Cash Flow
-10.1M
↓ 23.18%
Investing Cash Flow
-2.8M
↓ 11.13%
Financing Cash Flow
30.0M
↓ 16849.16%
Q2 FY23Q/Q Change
Operating Cash Flow
5.8M
↓ 157.14%
Investing Cash Flow
-2.7M
↓ 1.96%
Financing Cash Flow
-50.1M
↓ 267.03%

Technicals Summary

Sell

Neutral

Buy

Cardlytics Inc is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cardlytics Inc
Cardlytics Inc
-6.74%
4.28%
73.75%
-89.96%
-17.42%
Ziff Davis Inc
Ziff Davis Inc
-19.05%
-20.3%
-34.31%
-59.87%
-59.87%
Cimpress N.v.
Cimpress N.v.
3.62%
41.4%
105.3%
-9.56%
-0.82%
Omnicom Group Inc.
Omnicom Group Inc.
-0.32%
22.73%
-3.84%
11.36%
11.36%
Criteo Sa
Criteo Sa
-3.68%
18.89%
9.91%
-3.95%
54.98%
Interpublic Group Of Companies, Inc.
Interpublic Group Of Companies, Inc.
-6.66%
4.27%
-21.19%
-0.56%
33.64%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cardlytics Inc
Cardlytics Inc
NA
NA
NA
0.01
-0.78
-0.06
NA
3.39
Ziff Davis Inc
Ziff Davis Inc
57.36
57.36
0.84
6.58
0.02
0.03
NA
41.08
Cimpress N.v.
Cimpress N.v.
58.12
58.12
-9.11
3.32
0.0
0.07
NA
-20.75
Omnicom Group Inc.
Omnicom Group Inc.
13.16
13.16
1.45
7.81
0.33
0.05
0.03
18.26
Criteo Sa
Criteo Sa
38.24
38.24
0.89
3.36
0.05
0.03
NA
19.36
Interpublic Group Of Companies, Inc.
Interpublic Group Of Companies, Inc.
10.65
10.65
11.91
2.87
0.29
0.05
0.04
10.41
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cardlytics Inc
Cardlytics Inc
Buy
$634.0M
-17.42%
NA
-43.56%
Ziff Davis Inc
Ziff Davis Inc
Buy
$2.4B
-59.87%
57.36
3.04%
Cimpress N.v.
Cimpress N.v.
Buy
$2.4B
-0.82%
58.12
1.31%
Omnicom Group Inc.
Omnicom Group Inc.
Hold
$17.9B
11.36%
13.16
9.47%
Criteo Sa
Criteo Sa
Buy
$1.9B
54.98%
38.24
2.73%
Interpublic Group Of Companies, Inc.
Interpublic Group Of Companies, Inc.
Hold
$11.5B
33.64%
10.65
10.09%

Institutional Holdings

  • BlackRock Inc

    6.60%

  • Vanguard Group Inc

    4.88%

  • 683 Capital Management LLC

    3.48%

  • KPS Global Asset Management UK Ltd

    2.76%

  • Worldly Partners Management LLC

    2.63%

  • Morgan Stanley - Brokerage Accounts

    2.52%

Corporate Announcements

  • Cardlytics Inc Earnings

    Cardlytics Inc’s price-to-earnings ratio stands at None

    Read More

Company Information

cardlytics uses purchase-based intelligence to make marketing more relevant and measurable. we partner with more than 2,000 financial institutions to run their banking rewards programs that promote customer loyalty and deepen banking relationships. in turn, we have a secure view into where and when consumers are spending their money. we use these insights to help marketers identify, reach and influence likely buyers at scale, as well as measure the true sales impact of marketing campaigns. at cardlytics, we are analysts, developers, and data scientists. we are marketers, account managers, and consultants to our clients. we are all focused on making sense of the data we see to make it informative and actionable for our partners. headquartered in atlanta, ga, with offices in new york city, london, san francisco, and chicago, our team rallies around a common desire to win and to help our clients win. we are focused on building a revolutionizing company, but we still care about each other

Organization
Cardlytics Inc
Employees
434
CEO
Mr. Karim Temsamani
Industry
Technology Services

Discover More

FAQs